Zdrowie i gospodarka · 02/10/2020

FDA Releases Draft Guidance for Developing Drugs and Biologics for Bladder Cancer Treatment

The Food and Drug Administration (FDA) has released a draft guidance for the development of drugs and biologics for the adjuvant treatment of muscle-invasive bladder cancer, aiming to facilitate the creation of new treatments for this condition.